• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于可解释的机器学习模型预测中国 2 型糖尿病患者亚临床动脉粥样硬化风险。

Predicting the risk of subclinical atherosclerosis based on interpretable machine models in a Chinese T2DM population.

机构信息

Department of Endocrinology, The First Affiliated Hospital of Ningbo University, Ningbo University, Ningbo, China.

Health Science Center, Ningbo University, Ningbo, China.

出版信息

Front Endocrinol (Lausanne). 2024 Feb 27;15:1332982. doi: 10.3389/fendo.2024.1332982. eCollection 2024.

DOI:10.3389/fendo.2024.1332982
PMID:38476673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10929018/
Abstract

BACKGROUND

Cardiovascular disease (CVD) has emerged as a global public health concern. Identifying and preventing subclinical atherosclerosis (SCAS), an early indicator of CVD, is critical for improving cardiovascular outcomes. This study aimed to construct interpretable machine learning models for predicting SCAS risk in type 2 diabetes mellitus (T2DM) patients.

METHODS

This study included 3084 T2DM individuals who received health care at Zhenhai Lianhua Hospital, Ningbo, China, from January 2018 to December 2022. The least absolute shrinkage and selection operator combined with random forest-recursive feature elimination were used to screen for characteristic variables. Linear discriminant analysis, logistic regression, Naive Bayes, random forest, support vector machine, and extreme gradient boosting were employed in constructing risk prediction models for SCAS in T2DM patients. The area under the receiver operating characteristic curve (AUC) was employed to assess the predictive capacity of the model through 10-fold cross-validation. Additionally, the SHapley Additive exPlanations were utilized to interpret the best-performing model.

RESULTS

The percentage of SCAS was 38.46% (n=1186) in the study population. Fourteen variables, including age, white blood cell count, and basophil count, were identified as independent risk factors for SCAS. Nine predictors, including age, albumin, and total protein, were screened for the construction of risk prediction models. After validation, the random forest model exhibited the best clinical predictive value in the training set with an AUC of 0.729 (95% CI: 0.709-0.749), and it also demonstrated good predictive value in the internal validation set [AUC: 0.715 (95% CI: 0.688-0.742)]. The model interpretation revealed that age, albumin, total protein, total cholesterol, and serum creatinine were the top five variables contributing to the prediction model.

CONCLUSION

The construction of SCAS risk models based on the Chinese T2DM population contributes to its early prevention and intervention, which would reduce the incidence of adverse cardiovascular prognostic events.

摘要

背景

心血管疾病(CVD)已成为全球公共卫生关注的焦点。识别和预防亚临床动脉粥样硬化(SCAS)是改善心血管结局的关键,SCAS 是 CVD 的早期指标。本研究旨在构建可解释的机器学习模型,以预测 2 型糖尿病(T2DM)患者的 SCAS 风险。

方法

本研究纳入了 2018 年 1 月至 2022 年 12 月在宁波镇海龙莲医院接受医疗保健的 3084 例 T2DM 患者。使用最小绝对收缩和选择算子(LASSO)结合随机森林递归特征消除来筛选特征变量。采用线性判别分析、逻辑回归、朴素贝叶斯、随机森林、支持向量机和极端梯度提升来构建 T2DM 患者 SCAS 风险预测模型。通过 10 折交叉验证,使用受试者工作特征曲线下面积(AUC)评估模型的预测能力。此外,还利用 SHapley Additive exPlanations 来解释表现最佳的模型。

结果

研究人群中 SCAS 的比例为 38.46%(n=1186)。年龄、白细胞计数和嗜碱性粒细胞计数等 14 个变量被确定为 SCAS 的独立危险因素。筛选出年龄、白蛋白和总蛋白等 9 个预测因子用于构建风险预测模型。经过验证,随机森林模型在训练集中具有最佳的临床预测价值,AUC 为 0.729(95%CI:0.709-0.749),在内部验证集中也具有良好的预测价值[AUC:0.715(95%CI:0.688-0.742)]。模型解释表明,年龄、白蛋白、总蛋白、总胆固醇和血清肌酐是预测模型的前五个最重要的变量。

结论

基于中国 T2DM 人群构建的 SCAS 风险模型有助于其早期预防和干预,从而降低不良心血管预后事件的发生率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/bab47f248663/fendo-15-1332982-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/469d37cc8a23/fendo-15-1332982-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/3e508f36444b/fendo-15-1332982-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/4f60db6aa44c/fendo-15-1332982-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/3241ebba3b67/fendo-15-1332982-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/14332c846116/fendo-15-1332982-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/8c43e2bafaeb/fendo-15-1332982-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/56ce44dcbe1d/fendo-15-1332982-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/a113e10c3a93/fendo-15-1332982-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/2922b8ad63ac/fendo-15-1332982-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/054c6095f9b2/fendo-15-1332982-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/bab47f248663/fendo-15-1332982-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/469d37cc8a23/fendo-15-1332982-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/3e508f36444b/fendo-15-1332982-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/4f60db6aa44c/fendo-15-1332982-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/3241ebba3b67/fendo-15-1332982-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/14332c846116/fendo-15-1332982-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/8c43e2bafaeb/fendo-15-1332982-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/56ce44dcbe1d/fendo-15-1332982-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/a113e10c3a93/fendo-15-1332982-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/2922b8ad63ac/fendo-15-1332982-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/054c6095f9b2/fendo-15-1332982-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5b24/10929018/bab47f248663/fendo-15-1332982-g011.jpg

相似文献

1
Predicting the risk of subclinical atherosclerosis based on interpretable machine models in a Chinese T2DM population.基于可解释的机器学习模型预测中国 2 型糖尿病患者亚临床动脉粥样硬化风险。
Front Endocrinol (Lausanne). 2024 Feb 27;15:1332982. doi: 10.3389/fendo.2024.1332982. eCollection 2024.
2
Predicting the 5-Year Risk of Nonalcoholic Fatty Liver Disease Using Machine Learning Models: Prospective Cohort Study.利用机器学习模型预测非酒精性脂肪性肝病的 5 年风险:前瞻性队列研究。
J Med Internet Res. 2023 Sep 12;25:e46891. doi: 10.2196/46891.
3
Development and Validation of an Explainable Machine Learning Model for Predicting Myocardial Injury After Noncardiac Surgery in Two Centers in China: Retrospective Study.中国两个中心用于预测非心脏手术后心肌损伤的可解释机器学习模型的开发与验证:一项回顾性研究
JMIR Aging. 2024 Jul 26;7:e54872. doi: 10.2196/54872.
4
Predictive model and risk analysis for peripheral vascular disease in type 2 diabetes mellitus patients using machine learning and shapley additive explanation.基于机器学习和 Shapley 加法解释的 2 型糖尿病患者外周血管疾病预测模型和风险分析。
Front Endocrinol (Lausanne). 2024 Feb 28;15:1320335. doi: 10.3389/fendo.2024.1320335. eCollection 2024.
5
Predicting diabetic kidney disease for type 2 diabetes mellitus by machine learning in the real world: a multicenter retrospective study.基于真实世界数据应用机器学习预测 2 型糖尿病患者的糖尿病肾病:一项多中心回顾性研究。
Front Endocrinol (Lausanne). 2023 Jul 4;14:1184190. doi: 10.3389/fendo.2023.1184190. eCollection 2023.
6
Machine Learning-Based Prediction of Acute Kidney Injury Following Pediatric Cardiac Surgery: Model Development and Validation Study.基于机器学习的小儿心脏手术后急性肾损伤预测:模型开发与验证研究。
J Med Internet Res. 2023 Jan 5;25:e41142. doi: 10.2196/41142.
7
Machine learning for characterizing risk of type 2 diabetes mellitus in a rural Chinese population: the Henan Rural Cohort Study.基于中国农村人群的机器学习特征分析 2 型糖尿病风险:河南农村队列研究。
Sci Rep. 2020 Mar 10;10(1):4406. doi: 10.1038/s41598-020-61123-x.
8
Prediction Model of Osteonecrosis of the Femoral Head After Femoral Neck Fracture: Machine Learning-Based Development and Validation Study.股骨颈骨折后股骨头坏死的预测模型:基于机器学习的开发与验证研究
JMIR Med Inform. 2021 Nov 19;9(11):e30079. doi: 10.2196/30079.
9
Application of machine learning model in predicting the likelihood of blood transfusion after hip fracture surgery.机器学习模型在预测髋部骨折手术后输血可能性中的应用。
Aging Clin Exp Res. 2023 Nov;35(11):2643-2656. doi: 10.1007/s40520-023-02550-4. Epub 2023 Sep 21.
10
Prediction of 3-year risk of diabetic kidney disease using machine learning based on electronic medical records.基于电子病历的机器学习预测糖尿病肾病 3 年风险。
J Transl Med. 2022 Mar 26;20(1):143. doi: 10.1186/s12967-022-03339-1.

引用本文的文献

1
Overcoming Missing Data: Accurately Predicting Cardiovascular Risk in Type 2 Diabetes, A Systematic Review.克服数据缺失:2型糖尿病心血管风险的准确预测,一项系统评价
J Diabetes. 2025 Jan;17(1):e70049. doi: 10.1111/1753-0407.70049.
2
Association between metabolic score of visceral fat and carotid atherosclerosis in Chinese health screening population: a cross-sectional study.中国健康体检人群内脏脂肪代谢评分与颈动脉粥样硬化的相关性:一项横断面研究。
BMC Public Health. 2024 Jun 28;24(1):1723. doi: 10.1186/s12889-024-19186-2.

本文引用的文献

1
Can Machine Learning Aid the Selection of Percutaneous vs Surgical Revascularization?机器学习能否辅助经皮与手术血运重建的选择?
J Am Coll Cardiol. 2023 Nov 28;82(22):2113-2124. doi: 10.1016/j.jacc.2023.09.818.
2
Artificial intelligence in clinical medicine: catalyzing a sustainable global healthcare paradigm.临床医学中的人工智能:催化可持续的全球医疗保健范式。
Front Artif Intell. 2023 Aug 29;6:1227091. doi: 10.3389/frai.2023.1227091. eCollection 2023.
3
Novel Insights into the Molecular Mechanisms of Atherosclerosis.动脉粥样硬化分子机制的新见解。
Int J Mol Sci. 2023 Aug 30;24(17):13434. doi: 10.3390/ijms241713434.
4
The triglyceride glucose index was U-shape associated with all-cause mortality in population with cardiovascular diseases.在心血管疾病人群中,甘油三酯葡萄糖指数与全因死亡率呈U形关联。
Diabetol Metab Syndr. 2023 Sep 7;15(1):181. doi: 10.1186/s13098-023-01153-3.
5
Atherosclerotic Disease: Pathogenesis and Approaches to Management.动脉粥样硬化性疾病:发病机制与治疗方法。
Med Clin North Am. 2023 Sep;107(5):793-805. doi: 10.1016/j.mcna.2023.04.004. Epub 2023 Jun 1.
6
Addendum. 2. Classification and Diagnosis of Diabetes: Standards of Care in Diabetes-2023. Diabetes Care 2023;46(Suppl. 1):S19-S40.附录2. 糖尿病的分类与诊断:《2023年糖尿病医疗护理标准》。《糖尿病护理》2023年;46(增刊1):S19 - S40。
Diabetes Care. 2023 Sep 1;46(9):1715. doi: 10.2337/dc23-ad08.
7
The atherogenic index of plasma and carotid atherosclerosis in a community population: a population-based cohort study in China.血浆致动脉粥样硬化指数与颈动脉粥样硬化在社区人群中的关系:中国基于人群的队列研究。
Cardiovasc Diabetol. 2023 May 27;22(1):125. doi: 10.1186/s12933-023-01839-y.
8
Differences and Associations of NLRP3 Inflammasome Levels with Interleukins 1α, 1β, 33 and 37 in Adults with Prediabetes and Type 2 Diabetes Mellitus.成人糖尿病前期和2型糖尿病患者中NLRP3炎性小体水平与白细胞介素1α、1β、33和37的差异及相关性
Biomedicines. 2023 Apr 28;11(5):1315. doi: 10.3390/biomedicines11051315.
9
Metabolic Score for Insulin Resistance (METS-IR) Predicts Adverse Cardiovascular Events in Patients with Type 2 Diabetes and Ischemic Cardiomyopathy.胰岛素抵抗代谢评分(METS-IR)可预测2型糖尿病合并缺血性心肌病患者的不良心血管事件。
Diabetes Metab Syndr Obes. 2023 May 5;16:1283-1295. doi: 10.2147/DMSO.S404878. eCollection 2023.
10
The Association between the Atherogenic Index of Plasma and Cardiometabolic Risk Factors: A Review.血浆致动脉粥样硬化指数与心血管代谢危险因素之间的关联:综述
Healthcare (Basel). 2023 Mar 28;11(7):966. doi: 10.3390/healthcare11070966.